New Analyses of Sotagliflozin From the SOLOIST-WHF and SCORED Trials in High Cardiovascular Risk Patients to be Presented at the American Heart Association Scientific Sessions 2022
Stock Information for Lexicon Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.